Drug Approval | July 01, 2022
Lupin receives approval from USFDA for Paliperidone extended-release tablets
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
LoveDepot.com addresses this gap that is yawning in the market
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
First and only PARP inhibitor to improve invasive disease-free survival in patients
Subscribe To Our Newsletter & Stay Updated
